TW408021B - Arrangement for the controlled release of active substance in the gastrointestinal tract with delayed pylorus passage - Google Patents

Arrangement for the controlled release of active substance in the gastrointestinal tract with delayed pylorus passage Download PDF

Info

Publication number
TW408021B
TW408021B TW88107903A TW88107903A TW408021B TW 408021 B TW408021 B TW 408021B TW 88107903 A TW88107903 A TW 88107903A TW 88107903 A TW88107903 A TW 88107903A TW 408021 B TW408021 B TW 408021B
Authority
TW
Taiwan
Prior art keywords
pouch
item
patent application
active substance
gastric juice
Prior art date
Application number
TW88107903A
Other languages
English (en)
Chinese (zh)
Inventor
Frank Becher
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of TW408021B publication Critical patent/TW408021B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
TW88107903A 1998-05-18 1999-05-15 Arrangement for the controlled release of active substance in the gastrointestinal tract with delayed pylorus passage TW408021B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1998122278 DE19822278A1 (de) 1998-05-18 1998-05-18 Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage

Publications (1)

Publication Number Publication Date
TW408021B true TW408021B (en) 2000-10-11

Family

ID=7868181

Family Applications (1)

Application Number Title Priority Date Filing Date
TW88107903A TW408021B (en) 1998-05-18 1999-05-15 Arrangement for the controlled release of active substance in the gastrointestinal tract with delayed pylorus passage

Country Status (5)

Country Link
EP (1) EP1083933A1 (de)
AU (1) AU3930799A (de)
DE (1) DE19822278A1 (de)
TW (1) TW408021B (de)
WO (1) WO1999059637A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19920837A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System für verlängerte Verweilzeit im Magen bzw. im Gastrointestinaltrakt
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
DE4419818C2 (de) * 1994-06-07 1998-10-22 Lohmann Therapie Syst Lts Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben
US6290989B1 (en) * 1997-01-14 2001-09-18 Lts Lohmann Therapie-Systeme Ag Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract

Also Published As

Publication number Publication date
DE19822278A1 (de) 1999-12-02
EP1083933A1 (de) 2001-03-21
WO1999059637A1 (de) 1999-11-25
AU3930799A (en) 1999-12-06

Similar Documents

Publication Publication Date Title
JP3825811B2 (ja) 胃腸系での活性物質の制御放出を用いた膨張性胃内貯留治療システム
Makwana et al. Advancements in controlled release gastroretentive drug delivery system: A review
Garg et al. Progress in controlled gastroretentive delivery systems
RU2242219C2 (ru) Расширяющаяся гастроретенционная терапевтическая система с длительным временем пребывания в желудке
Kalantzi et al. Recent advances in oral pulsatile drug delivery
Sharma et al. Gastroretentive drug delivery system: an overview
Borase Floating systems for oral controlled release drug delivery
TW408021B (en) Arrangement for the controlled release of active substance in the gastrointestinal tract with delayed pylorus passage
Neeharika et al. Chronotherapeutics: an optimizing approach to synchronize drug delivery with circadian rhythm
Hafeez et al. An overview on floating microsphere: Gastro Retention Floating drug delivery system (FDDS)
JP3801200B2 (ja) 幽門通過遅延を伴って消化管内で活性物質を制御して放出するための活性物質担体
Shah et al. A novel approach in gastro retentive drug delivery system: floating drug delivery system
Rashmitha et al. An update on floating drug delivery system: a review
Kandukoori et al. A review on floating drug delivery system
Soni et al. Updates on approaches to increase the residence time of drug in the stomach for site specific delivery: Brief review
Bhowmik et al. Gastro Retentive Drug Delivery Systems-a Novel Approaches of Controlled Drug Delivery Systems
CN108721246B (zh) 高分子材料构建的多单元超长效口服制剂及其制备方法
Sharma et al. A Review on Floating Drug Delivery System and Its Possible Future Scope
Rao et al. A CONCISE REVIEW ON FLOATING DRUG DELIVERY SYSTEM
Khatri et al. Emerging Trends in Floating Drug Delivery Systems
Katiyar A Review Report on Important Approches of Floating Drug Delivery System
Kumar et al. A REVIEW ON GASTRO RETENTIVE FLOATING DRUG DELIVERY SYSTEM (GRDDS)
PRAJAPATI et al. Indian Journal of Novel Drug Delivery
Kumar et al. Floating Drug Delivery System: A New Approach
Laxmi et al. Floating drug delivery approaches for prolonged gastric retention

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees